Medication info
Janurit Tablets 100 mg (Sitagliptin Hydrochloride Monohydrate)

Janurit Tablets 100 mg (Sitagliptin Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.4mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
Pale orange, round, biconvex film-coated tablet
Packaging
30 tablets - 10 tablets/PTP[x3]
Approval status
Active

MFDS item code 201907995 · Approved 2019.11.19 · Insurance code 671807130

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered at 100 mg once daily as monotherapy or in combination therapy, and the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Since dose adjustment according to renal function is necessary, assessment of renal function before treatment with this medicine and periodically thereafter is recommended. 1. No dose adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control in patients with type 2 diabetes
View approved original text

This medication is an adjunct to diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It can be administered alone, and in cases where blood sugar control is difficult with monotherapy in patients who have not received any diabetes medication initially, it can be used in combination with Metformin. Furthermore, it can be added to therapies that include sulfonylureas, Metformin, thiazolidinediones, and insulin when blood sugar control is insufficient with those agents alone. Additionally, when blood sugar control remains difficult despite various combination therapies, this medication can be additionally administered to improve blood glucose management. It is a medication that effectively aids patients in controlling their blood sugar levels in various situations.

How to take

Adult dose

This medicine is administered at 100 mg once daily as monotherapy or in combination therapy, and the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Since dose adjustment according to renal function is necessary, assessment of renal function before treatment with this medicine and periodically thereafter is recommended. 1. No dose adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication can cause severe allergic reactions, so if symptoms like skin rash or difficulty breathing appear within the first 3 months of administration, discontinue use immediately and consult a physician. Acute pancreatitis, a serious inflammation of the pancreas, may occur; therefore, if symptoms like abdominal pain, vomiting, or nausea arise, inform a healthcare professional immediately. It should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and it should not be administered if there is an allergy to this medication or any of its components. In patients with reduced kidney function, drug concentration may increase, requiring dosage adjustments, and regular monitoring of kidney function is important. There is a risk of hypoglycemia, so blood sugar should be frequently checked and dosage adjusted as necessary when used in conjunction with other hypoglycemic agents like insulin or sulfonylureas. This medication may cause side effects such as upper respiratory infections, headaches, nasopharyngitis, diarrhea, and abdominal pain, so consult a physician if symptoms persist or worsen. If severe joint pain or skin blisters occur, discontinue medication immediately and seek specialist care. Women who are pregnant or breastfeeding are advised not to use this medication, and safety in children and adolescents under 18 has not been established. Elderly patients may experience decreased kidney function, so a kidney function test is recommended prior to administration and careful monitoring during treatment is necessary. In case of overdose, routine emergency measures should be taken, and some of the drug may be removed by hemodialysis if necessary. This medication has a low potential for interactions with other drugs; however, monitoring by healthcare professionals is needed when used with cyclosporine or digoxin.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory infection
  • nasopharyngitis
  • headache
  • diarrhea
  • abdominal pain
Show 27 more
  • nausea
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • vesicular lichen planus
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute kidney failure
  • pneumonia
  • diabetic complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a sealed container that is air-tight, preferably at room temperature between 1 and 30 degrees Celsius. Proper storage helps to maintain the drug's effectiveness for a longer period.

Appearance and packaging

Appearance

Pale orange, round, biconvex film-coated tablet

Package unit

30 tablets - 10 tablets/PTP[x3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.